Rosen Law Firm Urges CVRx, Inc. (NASDAQ: CVRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--( BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx, Inc. (NASDAQ: CVRX) between July 25, 2023 and August 6, 2026, inclusive (the “Class Period”). CVRx is a commercial-stage medical device company.

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that CVRx, Inc. (NASDAQ: CVRX) Misled Investors Regarding its Business Operations.

According to the lawsuit, defendants made materially false and misleading statements about CVRx’s revenue growth, sales practices, regulatory compliance, reimbursement strategy, and sales-force productivity. Specifically, CVRx allegedly generated revenue in part through improper sales practices, including improper marketing of Barostim, kickbacks, and false information provided to government health insurance programs. This conduct allegedly exposed CVRx to liability under the False Claims Act and Anti-Kickback Statute. The complaint also alleges that, contrary to defendants’ assurances that the sales force had stabilized, turnover remained elevated and productivity lagged because many sales representatives needed more training and time to become productive. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against CVRx, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by January 8, 2027. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $2 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.